Literature DB >> 8149209

Comparison of oculomotor findings in the progressive ataxia syndromes.

C Moschner1, S Perlman, R W Baloh.   

Abstract

In this study we compare the results of quantitative oculomotor function testing in patients with Friedreich's ataxia (FA), olivopontocerebellar atrophy (OPCA) and cerebello-olivary atrophy (CA). Common features in all three syndromes included gaze-evoked nystagmus, saccade dysmetria and prolonged saccade reaction times. Patients with FA showed a characteristic combination of frequent saccadic intrusions, especially ocular flutter, relatively preserved optokinetic nystagmus (OKN) and smooth pursuit, and impaired vestibulo-ocular reflex (VOR) responses. In patients with CA saccadic intrusions were infrequent, OKN and smooth pursuit were severely impaired and VOR gain was normal or increased. Results in OPCA were more variable. When present, slowing of saccades or the combined loss of pursuit and vestibular function were characteristic for OPCA. The ability to suppress the VOR with a head fixed target was relatively preserved in FA, normal to moderately impaired in OPCA and always severely impaired in CA. We conclude that oculomotor testing is useful in the differential diagnosis of the progressive ataxia syndromes.

Entities:  

Mesh:

Year:  1994        PMID: 8149209     DOI: 10.1093/brain/117.1.15

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  15 in total

1.  Progressive ataxia due to a missense mutation in a calcium-channel gene.

Authors:  Q Yue; J C Jen; S F Nelson; R W Baloh
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

Review 2.  Ophthalmic manifestations of inherited neurodegenerative disorders.

Authors:  Hannah M Kersten; Richard H Roxburgh; Helen V Danesh-Meyer
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

3.  Deficits of cortical oculomotor mechanisms in cerebellar atrophy patients.

Authors:  F Filippopulos; T Eggert; A Straube
Journal:  Exp Brain Res       Date:  2012-11-16       Impact factor: 1.972

4.  Predicting and correcting ataxia using a model of cerebellar function.

Authors:  Nasir H Bhanpuri; Allison M Okamura; Amy J Bastian
Journal:  Brain       Date:  2014-05-08       Impact factor: 13.501

5.  Vestibulo-ocular arreflexia in families with spinocerebellar ataxia type 3 (Machado-Joseph disease).

Authors:  C R Gordon; V Joffe; G Vainstein; N Gadoth
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

6.  Saccade dysfunction associated with chronic petrol sniffing and lead encephalopathy.

Authors:  S Cairney; P Maruff; C B Burns; J Currie; B J Currie
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

7.  A clinical and genetic study in a large cohort of patients with spinocerebellar ataxia type 6.

Authors:  Hiroki Takahashi; Kinya Ishikawa; Takeshi Tsutsumi; Hiroto Fujigasaki; Akihiro Kawata; Ryoichi Okiyama; Tsuneo Fujita; Kazuo Yoshizawa; Shigeki Yamaguchi; Hitoshi Tomiyasu; Fumihito Yoshii; Kazuko Mitani; Natsue Shimizu; Mineo Yamazaki; Tomoyuki Miyamoto; Tomoyuki Orimo; Shin'ichi Shoji; Ken Kitamura; Hidehiro Mizusawa
Journal:  J Hum Genet       Date:  2004       Impact factor: 3.172

Review 8.  Linking Essential Tremor to the Cerebellum: Physiological Evidence.

Authors:  Pavel Filip; Ovidiu V Lungu; Mario-Ubaldo Manto; Martin Bareš
Journal:  Cerebellum       Date:  2016-12       Impact factor: 3.847

9.  Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients.

Authors:  Caterina Mariotti; Dario Alpini; Roberto Fancellu; Paola Soliveri; Marina Grisoli; Sabrina Ravaglia; Carlo Lovati; Vincenza Fetoni; Giorgio Giaccone; Alessia Castucci; Franco Taroni; Cinzia Gellera; Stefano Di Donato
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 4.849

10.  Sensorimotor processing for balance in spinocerebellar ataxia type 6.

Authors:  Lisa M Bunn; Jonathan F Marsden; Daniel C Voyce; Paola Giunti; Brian L Day
Journal:  Mov Disord       Date:  2015-04-16       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.